z-logo
Premium
Does end‐of‐treatment FDG ‐ PET provide any additional prognostic value to the pre‐treatment NCCN ‐ IPI score?
Author(s) -
Adams Hugo J. A.,
Kwee Thomas C.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14052
Subject(s) - medicine , international prognostic index , diffuse large b cell lymphoma , vincristine , positron emission tomography , rituximab , nuclear medicine , lymphoma , oncology , cyclophosphamide , chemotherapy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom